Antihypertensive medication adherence in cancer survivors and its affecting factors

Results of a Korean population-based study

Dong Wook Shin, Jong Hyock Park, Jae Hyun Park, Euncheol Park, So Young Kim, Sung Gyeong Kim, Jin Young Choi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: Cancer survivors have been reported to receive less care for other conditions than the general population; however, it is not clear whether patients' behavior also contribute to this. The present study was performed to examine cancer survivors' adherence to antihypertensive medication and factors associated with it, compared to the general population. Methods: We used pharmacy claims and enrollment data from the National Health Insurance, which covers 97% of the Korean population. In total, 2,455,193 subjects, including 12,636 (0.5%) cancer survivors, who were prescribed antihypertensive medications during the calendar year 2004 were identified. A cumulative medication adherence of 80% or above was defined as appropriate medication adherence. Two separate multiple logistic regressions were developed to compare the proportion of appropriate adherence between two populations and to identify factors affecting medication adherence in cancer survivors. Results: Cancer survivors were less likely to have an appropriate medication adherence than the general population (adjusted odds ratio = 0.85; 95% CI, 0.82-0.88). Significant variation was observed in medication adherence according to cancer type. Several other factors, such as older age, low income, living in a rural area, and antihypertensive medication duration, also affected antihypertensive medication adherence. Contrary to the general population, younger survivors showed higher adherence. Conclusions: Clinicians involved in survivor care should check patient adherence to antihypertensive medication, as well as assess the possible reasons for nonadherence. Further studies are warranted to determine the reasons for nonadherence and to establish effective interventions in this vulnerable population.

Original languageEnglish
Pages (from-to)211-220
Number of pages10
JournalSupportive Care in Cancer
Volume19
Issue number2
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Medication Adherence
Antihypertensive Agents
Survivors
Population
Neoplasms
National Health Programs
Vulnerable Populations
Patient Compliance
Logistic Models
Odds Ratio

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Shin, Dong Wook ; Park, Jong Hyock ; Park, Jae Hyun ; Park, Euncheol ; Kim, So Young ; Kim, Sung Gyeong ; Choi, Jin Young. / Antihypertensive medication adherence in cancer survivors and its affecting factors : Results of a Korean population-based study. In: Supportive Care in Cancer. 2011 ; Vol. 19, No. 2. pp. 211-220.
@article{bb7218eeadf449e397982c281363834d,
title = "Antihypertensive medication adherence in cancer survivors and its affecting factors: Results of a Korean population-based study",
abstract = "Purpose: Cancer survivors have been reported to receive less care for other conditions than the general population; however, it is not clear whether patients' behavior also contribute to this. The present study was performed to examine cancer survivors' adherence to antihypertensive medication and factors associated with it, compared to the general population. Methods: We used pharmacy claims and enrollment data from the National Health Insurance, which covers 97{\%} of the Korean population. In total, 2,455,193 subjects, including 12,636 (0.5{\%}) cancer survivors, who were prescribed antihypertensive medications during the calendar year 2004 were identified. A cumulative medication adherence of 80{\%} or above was defined as appropriate medication adherence. Two separate multiple logistic regressions were developed to compare the proportion of appropriate adherence between two populations and to identify factors affecting medication adherence in cancer survivors. Results: Cancer survivors were less likely to have an appropriate medication adherence than the general population (adjusted odds ratio = 0.85; 95{\%} CI, 0.82-0.88). Significant variation was observed in medication adherence according to cancer type. Several other factors, such as older age, low income, living in a rural area, and antihypertensive medication duration, also affected antihypertensive medication adherence. Contrary to the general population, younger survivors showed higher adherence. Conclusions: Clinicians involved in survivor care should check patient adherence to antihypertensive medication, as well as assess the possible reasons for nonadherence. Further studies are warranted to determine the reasons for nonadherence and to establish effective interventions in this vulnerable population.",
author = "Shin, {Dong Wook} and Park, {Jong Hyock} and Park, {Jae Hyun} and Euncheol Park and Kim, {So Young} and Kim, {Sung Gyeong} and Choi, {Jin Young}",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s00520-009-0802-4",
language = "English",
volume = "19",
pages = "211--220",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "2",

}

Antihypertensive medication adherence in cancer survivors and its affecting factors : Results of a Korean population-based study. / Shin, Dong Wook; Park, Jong Hyock; Park, Jae Hyun; Park, Euncheol; Kim, So Young; Kim, Sung Gyeong; Choi, Jin Young.

In: Supportive Care in Cancer, Vol. 19, No. 2, 01.01.2011, p. 211-220.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antihypertensive medication adherence in cancer survivors and its affecting factors

T2 - Results of a Korean population-based study

AU - Shin, Dong Wook

AU - Park, Jong Hyock

AU - Park, Jae Hyun

AU - Park, Euncheol

AU - Kim, So Young

AU - Kim, Sung Gyeong

AU - Choi, Jin Young

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Purpose: Cancer survivors have been reported to receive less care for other conditions than the general population; however, it is not clear whether patients' behavior also contribute to this. The present study was performed to examine cancer survivors' adherence to antihypertensive medication and factors associated with it, compared to the general population. Methods: We used pharmacy claims and enrollment data from the National Health Insurance, which covers 97% of the Korean population. In total, 2,455,193 subjects, including 12,636 (0.5%) cancer survivors, who were prescribed antihypertensive medications during the calendar year 2004 were identified. A cumulative medication adherence of 80% or above was defined as appropriate medication adherence. Two separate multiple logistic regressions were developed to compare the proportion of appropriate adherence between two populations and to identify factors affecting medication adherence in cancer survivors. Results: Cancer survivors were less likely to have an appropriate medication adherence than the general population (adjusted odds ratio = 0.85; 95% CI, 0.82-0.88). Significant variation was observed in medication adherence according to cancer type. Several other factors, such as older age, low income, living in a rural area, and antihypertensive medication duration, also affected antihypertensive medication adherence. Contrary to the general population, younger survivors showed higher adherence. Conclusions: Clinicians involved in survivor care should check patient adherence to antihypertensive medication, as well as assess the possible reasons for nonadherence. Further studies are warranted to determine the reasons for nonadherence and to establish effective interventions in this vulnerable population.

AB - Purpose: Cancer survivors have been reported to receive less care for other conditions than the general population; however, it is not clear whether patients' behavior also contribute to this. The present study was performed to examine cancer survivors' adherence to antihypertensive medication and factors associated with it, compared to the general population. Methods: We used pharmacy claims and enrollment data from the National Health Insurance, which covers 97% of the Korean population. In total, 2,455,193 subjects, including 12,636 (0.5%) cancer survivors, who were prescribed antihypertensive medications during the calendar year 2004 were identified. A cumulative medication adherence of 80% or above was defined as appropriate medication adherence. Two separate multiple logistic regressions were developed to compare the proportion of appropriate adherence between two populations and to identify factors affecting medication adherence in cancer survivors. Results: Cancer survivors were less likely to have an appropriate medication adherence than the general population (adjusted odds ratio = 0.85; 95% CI, 0.82-0.88). Significant variation was observed in medication adherence according to cancer type. Several other factors, such as older age, low income, living in a rural area, and antihypertensive medication duration, also affected antihypertensive medication adherence. Contrary to the general population, younger survivors showed higher adherence. Conclusions: Clinicians involved in survivor care should check patient adherence to antihypertensive medication, as well as assess the possible reasons for nonadherence. Further studies are warranted to determine the reasons for nonadherence and to establish effective interventions in this vulnerable population.

UR - http://www.scopus.com/inward/record.url?scp=78651506537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651506537&partnerID=8YFLogxK

U2 - 10.1007/s00520-009-0802-4

DO - 10.1007/s00520-009-0802-4

M3 - Article

VL - 19

SP - 211

EP - 220

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 2

ER -